Le Lézard
Classified in: Health
Subjects: NEW PRODUCTS/SERVICES, HEALTH, MISCELLANEOUS, Philanthropy

The Autism Speaks Canada Community Grants program is now accepting applications from organizations for 2023.


Toronto, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Autism Speaks Canada, a national charity dedicated to promoting solutions, across the spectrum and throughout the life span, has awarded over $4.8 million to 198 projects across the country since 2010.

 

Autism Speaks Canada's Community Grants are now open for submission. This year, the program has been structured to focus on addressing the social inclusion of autistic Canadians and their caregivers, specifically focusing on physical and emotional safety and community participation. The minimum award for each grant is $15,000 and the maximum award for each grant is $30,000. Grants are awarded through a rigorous review process, including a community panel of self-advocates, family members, friends, service providers, and research experts across Canada.

 

"We have aligned our 2023 Community Grants to match the current needs of autistic Canadians. We want to make a significant impact by supporting projects that increase the physical and emotional safety and security of autistic people. Autism Speaks Canada Community Grants is committed to supporting organizations providing access to supports and services across Canada." said Jill Farber the Executive Director at Autism Speaks Canada. The grants are meant to be responsive to the highest needs of our community and enhance the lives of autistic Canadians and their families. Autism Speaks Canada Community Grants will fund other charitable organizations. The deadline to apply is September 15, 2023.

 

About Autism Speaks Canada

Autism Speaks Canada is a national Canadian charity dedicated to promoting solutions, across the spectrum and throughout the life span.

Attachments



These press releases may also interest you

8 mai 2024
Tri-Tech expands emergency medical offering with the strategic acquisition of SAM Medical
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

8 mai 2024
Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

8 mai 2024
Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

8 mai 2024
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

8 mai 2024
Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

8 mai 2024
NCPDP Announces Highlights from its 2024 Annual Conference, "Innovation Starts Here"
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...

More news about Health...


News published on and distributed by: